Evidence map›Paper›PMID 28702842›Full record

ArticleHuman cell2017

Essential role of SH3GL1 in interleukin-6(IL-6)- and vascular endothelial growth factor (VEGF)-triggered p130

En-Qi Li, Jin-Li Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Human cell, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

En-Qi LiDepartment of Orthopaedics, Tianjin Hospital, No. 406 Jiefang South Road, Hexi District, Tianjin, 300211, China.
Jin-Li ZhangDepartment of Orthopaedics, Tianjin Hospital, No. 406 Jiefang South Road, Hexi District, Tianjin, 300211, China. zhangyansong1981@126.com.
Tianjin Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We recently demonstrated that interleukin-6 (IL-6)- and vascular endothelial growth factor (VEGF)-induced osteosarcoma (OS) cell proliferation and migration are parallel to significant increased expression of SH3GL1 and the phosphorylation level of P130

Indexed as

AdultCell Line, TumorCell MovementCell ProliferationCrk-Associated Substrate ProteinFemaleGene ExpressionHumansInterleukin-6Intracellular Signaling Peptides and ProteinsMaleMolecular Targeted TherapyOsteosarcomaVascular Endothelial Growth Factor ACrk-Associated Substrate ProteinInterleukin-6Intracellular Signaling Peptides and ProteinsSH3GL1 protein, humanVascular Endothelial Growth Factor ACell migrationOsteosarcomaP130casProliferationSH3GL1

Identifiers

PMID28702842
OpenAlexW2735859150

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.